Ligand Pharmaceuticals Incorporated
NASDAQLGND short interest plummets 32% in one week to 10.7% of float, reversing aggressive build as shorts exit amid analyst upgrades.
Snapshot as of 2 Aug 2026
LGND enters the back half of July with a notable reversal: the short squeeze that never quite came is now unwinding, even as analysts scramble to lift targets toward a stock price they've spent months chasing. The most…
LGND heads into the week at $319.43 with a striking split: the Street just raised its price target to a 52-week high while short sellers have quietly doubled their position over the past month. The tension between…
Ligand Pharmaceuticals heads into the final weeks of Q2 with a sharp tension at its centre: the stock is up 20% in a month, directors are cashing out in size, and shorts are quietly rebuilding. The insider selling is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LGND — free to start on ORTEX.
Sign up for free →Open LGND on ORTEX